Brokers Set Expectations for HCA Healthcare Q2 Earnings

HCA Healthcare, Inc. (NYSE:HCA) – Equities researchers at Leerink Partnrs upped their Q2 2025 earnings estimates for HCA Healthcare in a note issued to investors on Monday, April 28th. Leerink Partnrs analyst W. Mayo now anticipates that the company will post earnings of $6.51 per share for the quarter, up from their previous forecast of $6.37. The consensus estimate for HCA Healthcare’s current full-year earnings is $24.98 per share. Leerink Partnrs also issued estimates for HCA Healthcare’s Q3 2025 earnings at $5.84 EPS, Q4 2025 earnings at $7.01 EPS, FY2025 earnings at $25.82 EPS, Q1 2026 earnings at $7.27 EPS, Q2 2026 earnings at $7.40 EPS, Q3 2026 earnings at $6.79 EPS, Q4 2026 earnings at $8.56 EPS, FY2026 earnings at $30.02 EPS, FY2027 earnings at $34.11 EPS, FY2028 earnings at $38.44 EPS and FY2029 earnings at $43.24 EPS.

HCA has been the subject of a number of other reports. Barclays reduced their price target on shares of HCA Healthcare from $392.00 to $366.00 and set an “overweight” rating for the company in a research report on Monday, January 27th. Bank of America lowered their price target on HCA Healthcare from $380.00 to $370.00 and set a “buy” rating on the stock in a report on Monday, January 27th. Baird R W cut shares of HCA Healthcare from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, April 15th. Guggenheim started coverage on shares of HCA Healthcare in a research note on Wednesday, April 9th. They issued a “neutral” rating for the company. Finally, StockNews.com raised shares of HCA Healthcare from a “hold” rating to a “buy” rating in a report on Monday. One investment analyst has rated the stock with a sell rating, six have given a hold rating, twelve have given a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $381.13.

HCA Healthcare Trading Up 1.4 %

Shares of HCA Healthcare stock opened at $345.38 on Wednesday. HCA Healthcare has a 12-month low of $289.98 and a 12-month high of $417.14. The company has a current ratio of 1.08, a quick ratio of 0.97 and a debt-to-equity ratio of 69.07. The company has a market cap of $85.03 billion, a price-to-earnings ratio of 15.72, a PEG ratio of 1.10 and a beta of 1.48. The company’s 50-day moving average price is $331.02 and its 200-day moving average price is $331.49.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings results on Friday, April 25th. The company reported $6.45 EPS for the quarter, topping analysts’ consensus estimates of $5.75 by $0.70. The firm had revenue of $18.32 billion during the quarter, compared to analyst estimates of $18.26 billion. HCA Healthcare had a return on equity of 586.47% and a net margin of 8.16%. The business’s revenue for the quarter was up 5.7% on a year-over-year basis. During the same period last year, the company earned $5.36 earnings per share.

HCA Healthcare Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Monday, June 30th. Stockholders of record on Monday, June 16th will be paid a dividend of $0.72 per share. This represents a $2.88 annualized dividend and a dividend yield of 0.83%. The ex-dividend date of this dividend is Monday, June 16th. HCA Healthcare’s dividend payout ratio (DPR) is 12.81%.

Insider Buying and Selling

In other news, SVP Jennifer Berres sold 9,533 shares of the business’s stock in a transaction that occurred on Friday, February 14th. The stock was sold at an average price of $322.59, for a total transaction of $3,075,250.47. Following the transaction, the senior vice president now directly owns 15,412 shares of the company’s stock, valued at approximately $4,971,757.08. The trade was a 38.22 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 1.30% of the stock is owned by insiders.

Institutional Inflows and Outflows

A number of hedge funds have recently added to or reduced their stakes in HCA. Genus Capital Management Inc. bought a new position in HCA Healthcare in the first quarter worth about $5,563,000. MJP Associates Inc. ADV bought a new position in shares of HCA Healthcare in the 1st quarter worth approximately $222,000. Cerity Partners LLC boosted its position in shares of HCA Healthcare by 9.7% during the first quarter. Cerity Partners LLC now owns 30,844 shares of the company’s stock valued at $10,658,000 after purchasing an additional 2,718 shares in the last quarter. Alps Advisors Inc. raised its holdings in HCA Healthcare by 44.9% in the first quarter. Alps Advisors Inc. now owns 1,332 shares of the company’s stock worth $460,000 after purchasing an additional 413 shares in the last quarter. Finally, Allworth Financial LP boosted its holdings in shares of HCA Healthcare by 8.7% during the 1st quarter. Allworth Financial LP now owns 798 shares of the company’s stock valued at $272,000 after buying an additional 64 shares in the last quarter. 62.73% of the stock is owned by hedge funds and other institutional investors.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.